B7-H1 Antigen
/ genetics
Biomarkers, Tumor
/ analysis
Carcinoma, Non-Small-Cell Lung
/ diagnostic imaging
Fluorodeoxyglucose F18
/ metabolism
Glycolysis
Humans
Lung Neoplasms
/ diagnostic imaging
Lymphocytes, Tumor-Infiltrating
/ immunology
Positron-Emission Tomography
/ methods
Prognosis
Radiopharmaceuticals
/ metabolism
Retrospective Studies
Survival Rate
Transcriptome
Tumor Microenvironment
/ immunology
Positron emission tomography
Resected non-small cell lung cancer
Tumor glycolysis
Tumor immunometabolic phenotypes
Journal
Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
26
09
2019
accepted:
31
03
2020
pubmed:
18
4
2020
medline:
21
7
2020
entrez:
18
4
2020
Statut:
ppublish
Résumé
Enhanced tumor glycolytic activity is a mechanism by which tumors induce an immunosuppressive environment to resist adoptive T cell therapy; therefore, methods of assessing intratumoral glycolytic activity are of considerable clinical interest. In this study, we characterized the relationships among tumor
Identifiants
pubmed: 32300858
doi: 10.1007/s00262-020-02560-5
pii: 10.1007/s00262-020-02560-5
pmc: PMC7997043
mid: NIHMS1649875
doi:
Substances chimiques
B7-H1 Antigen
0
Biomarkers, Tumor
0
CD274 protein, human
0
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1519-1534Subventions
Organisme : NCI NIH HHS
ID : R01 CA187076
Pays : United States
Organisme : Khalifa Bin Zayed Al Nahyan Foundation
ID : Khalifa Scholar Award
Organisme : Conquer Cancer Foundation (ASCO 2018 Career Development Award)
ID : 12895
Organisme : NCI NIH HHS
ID : P50 CA221703
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA070907
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA184845
Pays : United States
Organisme : Cancer Prevention and Research Institute of Texa
ID : RP170401
Organisme : DoD PROSPECT Grant
ID : W81XWH-07-1-0306
Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : MD Anderson Cancer Center Support Grant
ID : P30CA01667
Organisme : Lung SPORE
ID : 5 P50 CA070907
Références
Cancer Cell. 2016 Mar 14;29(3):285-296
pubmed: 26977880
Cell Metab. 2018 May 01;27(5):977-987.e4
pubmed: 29628419
Clin Cancer Res. 2016 Nov 1;22(21):5196-5203
pubmed: 27609841
Sci Transl Med. 2017 Nov 8;9(415):
pubmed: 29118262
Cancer Res. 2016 Jul 15;76(14):4136-48
pubmed: 27206847
Oncotarget. 2015 Jun 20;6(17):14982-92
pubmed: 25893381
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):56-66
pubmed: 28828507
Cell. 2017 Oct 5;171(2):358-371.e9
pubmed: 28985563
Cell. 2016 Feb 11;164(4):681-94
pubmed: 26853473
Mol Cell. 2019 Dec 5;76(5):838-851.e5
pubmed: 31564558
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
J Immunother Cancer. 2018 Jun 6;6(1):48
pubmed: 29871672
Nucl Med Commun. 2018 Feb;39(2):154-160
pubmed: 29227348
PLoS One. 2016 Jan 04;11(1):e0146195
pubmed: 26727114
J Immunother Cancer. 2018 Jun 22;6(1):63
pubmed: 29929551
J Thorac Oncol. 2007 Aug;2(8):706-14
pubmed: 17762336
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
J Nucl Med. 2014 Nov;55(11):1766-71
pubmed: 25342384
Cancer Res. 2013 Mar 1;73(5):1524-35
pubmed: 23288510
Ann Oncol. 2017 Jan 1;28(1):75-82
pubmed: 27687306
N Engl J Med. 2018 May 24;378(21):1976-1986
pubmed: 29658848
Cell. 2018 Nov 1;175(4):984-997.e24
pubmed: 30388455
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):241-51
pubmed: 25193652
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):466-72
pubmed: 20471184
Clin Cancer Res. 2015 Aug 1;21(15):3480-91
pubmed: 25878335
J Nucl Med. 2009 May;50 Suppl 1:97S-105S
pubmed: 19403880
PLoS One. 2013 Dec 18;8(12):e82241
pubmed: 24367507
Clin Cancer Res. 2016 Dec 15;22(24):6278-6289
pubmed: 27252415
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1954-61
pubmed: 27251642
J Thorac Oncol. 2018 Nov;13(11):1733-1742
pubmed: 29775807
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Nat Commun. 2017 May 26;8:15503
pubmed: 28548087
Lung Cancer. 2014 Feb;83(2):197-204
pubmed: 24365102
Front Immunol. 2017 Mar 08;8:248
pubmed: 28337200
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
Neoplasia. 2005 Apr;7(4):369-79
pubmed: 15967114
Clin Cancer Res. 2013 Mar 15;19(6):1577-86
pubmed: 23357979
J Immunother Cancer. 2015 Dec 15;3:42
pubmed: 26674611
J Nucl Med. 2013 Sep;54(9):1528-34
pubmed: 23864719
J Clin Invest. 2009 Oct;119(10):3011-23
pubmed: 19741298
Nature. 2017 Jun 15;546(7658):426-430
pubmed: 28607489
Nature. 2019 Nov;575(7782):380-384
pubmed: 31666695
J Nucl Med. 2014 Jun;55(6):884-90
pubmed: 24752671
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1164-71
pubmed: 21531085
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Cancer Discov. 2015 Aug;5(8):860-77
pubmed: 26069186
Nat Cell Biol. 2015 Apr;17(4):351-9
pubmed: 25774832
F1000Res. 2016 Jun 17;5:1408
pubmed: 27441086
Cancer Res. 2000 Feb 15;60(4):916-21
pubmed: 10706105
J Thorac Imaging. 2006 May;21(2):123-36
pubmed: 16770229
Immunity. 2018 Mar 20;48(3):399-416
pubmed: 29562192
Nucl Med Mol Imaging. 2019 Dec;53(6):386-395
pubmed: 31867074
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
Oncotarget. 2018 May 15;9(37):24801-24820
pubmed: 29872507
Nat Med. 2013 Sep;19(9):1114-23
pubmed: 23913124